FDA approves Omnipod 5 automated insulin delivery system for adults with Type 2 diabetes.

The FDA has approved Insulet's Omnipod 5 automated insulin delivery system for adults with Type 2 diabetes, expanding its initial use for Type 1 diabetes. The Omnipod 5 system connects to an alternate controller-enabled insulin pump and integrated continuous glucose monitor, providing a non-invasive option for diabetes management without needles for up to three days. The FDA's decision aims to increase access to diabetes management tools for millions of adults with Type 2 diabetes in the US.

August 26, 2024
63 Articles

Further Reading